|
RNF169 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.79879999995247E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.15870000000496E-05 |
| Normal-vs-Stage2 |
1.078760E-03 |
| Normal-vs-Stage3 |
1.60455999999032E-05 |
| Normal-vs-Stage4 |
3.7599999999971E-05 |
| Stage1-vs-Stage2 |
6.508000E-01 |
| Stage1-vs-Stage3 |
2.529000E-01 |
| Stage1-vs-Stage4 |
1.391240E-01 |
| Stage2-vs-Stage3 |
7.129400E-01 |
| Stage2-vs-Stage4 |
4.059000E-01 |
| Stage3-vs-Stage4 |
5.453400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.35240000001635E-06 |
| Normal-vs-AfricanAmerican |
1.285630E-01 |
| Normal-vs-Asian |
4.033700E-04 |
| Caucasian-vs-AfricanAmerican |
1.550560E-01 |
| Caucasian-vs-Asian |
6.938600E-01 |
| AfricanAmerican-vs-Asian |
1.411200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.82490000000257E-06 |
| Normal-vs-Female |
2.14979999999532E-05 |
| Male-vs-Female |
2.850600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.076260E-03 |
| Normal-vs-Age(41-60Yrs) |
2.08950000002428E-06 |
| Normal-vs-Age(61-80Yrs) |
1.60439999999928E-05 |
| Normal-vs-Age(81-100Yrs) |
9.580200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.303950E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.035180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.954790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.735400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.549600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.463400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.024570E-01 |
| Classical-VS-Follicular |
2.320000E-03 |
| Classical-VS-Other |
1.390560E-01 |
| Classical-VS-Normal |
4.208000E-04 |
| Tall-VS-Follicular |
7.458000E-01 |
| Tall-VS-Other |
4.782600E-01 |
| Tall-VS-Normal |
1.398840E-04 |
| Follicular-VS-Other |
6.174000E-01 |
| Follicular-VS-Normal |
3.38630000040752E-07 |
| Other-VS-Normal |
1.164010E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.79670000011978E-07 |
| Normal-vs-N1 |
5.73329999999928E-05 |
| N0-vs-N1 |
4.649400E-01 |
|
|
